Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Sorting through new biomarkers.

Wood FO, de Lemos JA.

Curr Cardiol Rep. 2008 Jul;10(4):319-26.

PMID:
18611367
2.

[Redefinition of myocardial infarction--relevance of biomarkers].

Weber M, Hamm C.

Herz. 2008 Mar;33(2):115-21. doi: 10.1007/s00059-008-3103-7. Review. German.

PMID:
18344030
3.

Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.

Palazzuoli A, Iovine F, Gallotta M, Nuti R.

Minerva Cardioangiol. 2007 Aug;55(4):491-6. Review.

PMID:
17653025
4.

Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes.

de Lemos JA, Morrow DA.

Rev Cardiovasc Med. 2003;4 Suppl 4:S37-46. Review.

PMID:
14564227
5.

Time to treatment and acute coronary syndromes: bridging the gap in rapid decision making.

Peacock WF.

Rev Cardiovasc Med. 2010;11 Suppl 2:S45-50. Review.

PMID:
20700102
6.

Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.

Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B.

J Am Coll Cardiol. 2009 Jul 21;54(4):357-64. doi: 10.1016/j.jacc.2009.03.056.

7.

Markers of acute coronary syndrome in emergency room.

Loria V, Dato I, De Maria GL, Biasucci LM.

Minerva Med. 2008 Oct;99(5):497-517. Review. English, Italian.

PMID:
18971915
8.

Cardiac biomarkers in acute coronary syndromes: a review.

Amodio G, Antonelli G, Di Serio F.

Curr Vasc Pharmacol. 2010 May;8(3):388-93. Review.

PMID:
19485924
9.

Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.

Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.

Indian Heart J. 2008 Nov-Dec;60(6):536-42.

PMID:
19276492
10.
11.

Biomarkers, C-reactive proteins and statins in acute coronary syndromes.

Ray KK.

Fundam Clin Pharmacol. 2007 Nov;21 Suppl 2:31-3. Review.

PMID:
18001319
12.

The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in non-ST-segment elevation acute coronary syndrome: results from CRUSADE.

Takakuwa KM, Ou FS, Peterson ED, Pollack CV Jr, Peacock WF, Hoekstra JW, Ohman EM, Gibler WB, Blomkalns AL, Roe MT.

Clin Cardiol. 2009 Sep;32(9):498-505. doi: 10.1002/clc.20626.

13.

Biomarkers in acute coronary syndrome and percutaneous coronary intervention.

Searle J, Danne O, Müller C, Mockel M.

Minerva Cardioangiol. 2011 Jun;59(3):203-23. Review.

PMID:
21516070
14.

Serological evidence of early remodeling in high-risk non-ST elevation acute coronary syndromes.

McGavigan AD, Maxwell PR, Dunn FG.

Int J Cardiol. 2008 Mar 28;125(1):22-7.

PMID:
17433479
15.

Natriuretic peptides in the prognosis and management of acute coronary syndromes.

de Lemos JA, Peacock WF, McCullough PA.

Rev Cardiovasc Med. 2010;11 Suppl 2:S24-34. Review.

PMID:
20700099
16.

Biochemical markers in acute coronary syndrome.

Ramasamy I.

Clin Chim Acta. 2011 Jul 15;412(15-16):1279-96. doi: 10.1016/j.cca.2011.04.003. Review.

PMID:
21501603
18.

Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications.

Farmakis D, Filippatos G, Tubaro M, Peacock WF, Disomma S, Mueller C, Kremastinos DT, Maisel AS.

Congest Heart Fail. 2008 Jul-Aug;14(4 Suppl 1):25-9. Review.

PMID:
18772630
19.

Role of biomarkers in risk stratification of acute coronary syndrome.

Nagesh CM, Roy A.

Indian J Med Res. 2010 Nov;132:627-33. Review.

20.

Current trends in diagnostic biomarkers of acute coronary syndrome.

Moe KT, Wong P.

Ann Acad Med Singapore. 2010 Mar;39(3):210-5. Review.

Items per page

Supplemental Content

Support Center